Let's not forget that Tony was not a CEO-type person. He
Let's not forget that Tony was not a CEO-type person. He ran manufacturing. And I would guess that he was very good at doing that; but it doesn't necessarily translate into CEO skills (and it wouldn't prepare him for e.g. raising money).
And before Tony, there was Ken Van Ness (who wasn't any good at all). But we shouldn't be comparing NP vs. bad choices, we should be comparing him against professional, experienced, effective CEOs.
++++
My other comment regarding the long pro/con NP debate, is, yes, NP did pursue MONO. But to say that no one else would have is a stretch or at least a guess IMHO.
One could definitely make a cogent argument that we would be better off without having pursued MONO. Our COMBO results were more than good enough very early on. And our parallel MONO trial is what kept changing the goal posts by the FDA. We had more data (from MONO), and they kept wanting more and more. It is very likely that the FDA would have kept our COMBO trial the same as IZ. We would have been approved a long time ago and with only a fraction of the money required to be raised and diluted.
Moreover, IMO, MONO was a natural outcome from Lero. And IMO it would have come out as a use case irrespective of who was CEO. e.g COMBO patients would have started using it as MONO. All the CCR5 research data would have provided direction that it would/could work as MONO. Overlap with other indications would have directed the company to look closer into MONO.
We will never know for sure. But let's give NP full credit for MONO. Even in that case, the COMPANY would have been better off after that point in time hiring a seasoned CEO for no other reason than managing the business aspects.
But we are where we are. And as I have stated many times in the past, I invested and continue to invest in the company knowing that we have a suboptimal CEO that has not maximized the potential of the company. But the product is SOOOO good that the shareholders and the patients will benefit greatly nonetheless.
1
CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Celebrating Boardroom Mavericks at NACD Gala September 2026 has brought some sparkling recognition to the elites guiding today's corporate governance landscapes. The National Association of Corporate Directors (NACD) has announced their Directorship 100 honorees, tipping their hats to stellar individuals firing on all cylinders in the boardroom. Who's Getting the Nod?...
Continue Reading
Trouble Brews at Electrical Consultants, Inc. Right on the heels of a long workday, some employees of Electrical Consultants, Inc. seem to be getting a double whammy. The company is tangled up in a class action lawsuit lodged by the well-known Blumenthal Nordrehaug Bhowmik De Blouw LLP. This ain't your everyday grievance, folks; we're talking meal and rest period...
Continue Reading
Every once in a while, a piece of tech comes along that makes you sit up and say, ‘Now that’s a game-changer!’ And with the recent rave reviews, Tenera Care seems to hit just that sweet spot for folks in the senior living game. By handing Dublin Glenn Memory Care the gold in the KISS category at the 2026 McKnight's Technology Awards, it’s clear the industry is...
Continue Reading
Game-Changer for AI Data Centers? Across the tech landscape, space is a premium, and Molex's new VersaBeam Mini arrives like a hail Mary in the fourth quarter. In AI data centers, squeezing down every single component counts—especially when optical density's in play. What we're seeing here is a potential paradigm shift. A 3x density improvement from a tiny 3.5 x 9 mm...
Continue Reading
It's not every day you see a company like Lititz Mutual making moves in the artificial intelligence (AI) arena. Based out of Lititz, Pennsylvania, this insurance firm has decided to shake things up with Guidewire's ProNavigator AI assistant. Forging New Paths in Insurance Lititz Mutual is set to inject some serious tech into their operations. The goal? Make life easier...
Continue Reading
A Busy Morning at the NYSE with Key Guests and Global Events In a world where high-stakes diplomacy and roaring market bells go hand in hand, today brings the U.S. Secretary of State, Marco Rubio, to the New York Stock Exchange. With the 81st Session of the United Nations General Assembly shaking up the Big Apple, the city finds itself at the intersection of politics and...
Continue Reading
New PostalAnnex Location Opens in Bastrop, TX Here's a fresh chapter in the books for Annex Brands, Inc. They've just cut the ribbon on a brand spanking new PostalAnnex in Bastrop, Texas, handing the reins over to eager fresh faces, Chetan Modi and Karan Desai. And you know what? This ain't just any regular location. It's a one-stop-shop for anything you could need, from...
Continue Reading
Just when you think you've seen it all in the world of craftsmanship, along comes a dynamo like Spencer Peterman. For over 25 years, he's been turning what others discard into treasures. Fallen trees? Most folks see firewood. Spencer sees a future masterpiece. And now, he’s rolling out the welcome mat for his loyal customers with a special sale that runs until December...
Continue Reading
Breaking New Ground in Cancer Immunotherapy Today feels like a pivotal day for Anixa Biosciences. Their announcement about securing a patent in Australia for their trailblazing breast cancer vaccine is like planting a flag on new, promising territory. This is no minor step; it's a strategic leap for the company as it strengthens its intellectual grip on the global...
Continue Reading
Breaking New Ground in Arlington and Baltimore Deepening their stake in the Capital Region's future, HNTB has thrown open new office doors in Arlington, Virginia, and Baltimore, Maryland. We're not just talking fancy buildings, folks—this is about securing a piece of the infrastructure pie that's only going to get bigger and tastier. Infrastructure's the backbone of...
Continue Reading
Top 5 Most Recently Viewed Articles
Macquarie's Inflation Insights Recent developments in core inflation have sparked interest, with December indicating a surprising dip that has alleviated some concerns about interest rate fluctuations. Despite this, Macquarie maintains its projection of a solitary cut to rates, signaling cautious optimism amid the ongoing disinflation narrative. Core Inflation Trends...
Continue Reading
Transforming Utility Network Deployments with Anterix Anterix (NASDAQ: ATEX), a prominent player in private wireless broadband for critical infrastructure, has teamed up with Crown Castle, a major tower company in the U.S., to unveil their innovative TowerX™ service. This collaboration marks a significant advancement in the deployment of 900 MHz private LTE networks,...
Continue Reading
Illuminate Rx Revolutionizes Pharmacy Management Illuminate Rx emerges as a cutting-edge pharmacy benefits manager (PBM) designed to enhance clarity and affordability in pharmacy benefits management. This innovative model, backed by RxBenefits' three-decade legacy, aims to address longstanding inefficiencies and simplify a complex industry plagued by jargon and rigid...
Continue Reading
Compass Diversified Holdings Facing Legal Troubles In a striking turn of events, Compass Diversified Holdings (NYSE: CODI) finds itself embroiled in a lawsuit alleging serious violations of federal securities laws. This development has prompted a surge of concern among investors, especially following recent admissions regarding discrepancies in the company’s financial...
Continue Reading
Unleashing the Power of Crypto Trading with BexBack Amid the rise of Bitcoin above the noteworthy threshold of $100,000, numerous analysts are suggesting that the cryptocurrency market has embarked on a promising bull run. In this dynamic climate, astute investors are likely to explore leveraged trading options. BexBack is emerging as a frontrunner in offering trading...
Continue Reading